Public Company News

Veoneer Provides Market Update

* Announces Completion of Sale of Arriver            * Signs Strategic Collaboration Agreement with Qualcomm Technologies             * SSW Partners to Launch Process to Find Long-term Strategic Buyers STOCKHOLM andNEW YORK, April 5, 2022 /PRNewswire/ -- Veoneer, Inc., the automotive technol...

2022-04-05 00:49 3176

TSYS names Zwipe and adds insight to the previously announced partnership in North America

OSLO, Norway, April 5, 2022 /PRNewswire/ -- With reference to Zwipe's announcement on15 December 2021, biometric fintech pioneer Zwipe can confirm that TSYS, a leading global provider of payment services to card issuers (and part of Global Payments Inc, a member of the S&P 500), chose to work wit...

2022-04-05 00:47 3287

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis

HONG KONG, April 4, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today dose administration for the first subject in a U.S. Phase I clinical tr...

2022-04-04 21:31 4250

ARTA TechFin Partners with Digital Technology of Insurance ("DTI") to Create Digital Insurance Platform in Greater Bay Area

  Technology Solutions, Wealth Management Industry Resource, Insurance Technology Innovation Centre in GBA by 2022Q3 ARTA: Break Barriers for Greatness HONG KONG, April 4, 2022 /PRNewswire/ -- Hong Kong's ARTA TechFin (00279.HK) ("ARTA") andChina's Digital Technology of Insurance ("DTI") today ...

2022-04-04 18:02 6733

Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province

HANGZHOU, China and SHAOXING, China, April 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets inZhejiang Province has been completed. On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"),...

2022-04-04 17:10 3953

Mycronic publishes Annual and Sustainability Report 2021

STOCKHOLM, April 4, 2022 /PRNewswire/ -- Mycronic AB (publ) today publishes its Annual and Sustainability Report 2021, which can be downloaded as a PDF from the company's websitewww.mycronic.com. A printed version of the Annual and Sustainability Report will be available mid-April and distribute...

2022-04-04 17:08 2668

Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients

Winners include Liberty Hospital, four Ardent Health Services hospitals, University of Iowa Hospitals & Clinics and Novant Health LONDON, April 4, 2022 /PRNewswire/ -- Today, Clarivate Healthcare Business InsightsTM , a part of Clarivate Plc (NYSE: CLVT), a global leader in providing trusted inf...

2022-04-04 16:00 3000

Hyundai Motor Group honors Infineon for supply competence and strategic cooperation for electric cars

MUNICH, Germany, April 4, 2022 /PRNewswire/ -- Hyundai Motor Group (HMG) has honored Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) as "Partner of the Year 2021" with the "Special Award for Supply Competence". The top global automaker recognized Infineon's efforts to stabilize uncertain suppl...

2022-04-04 15:00 5153

WA-based Golden State Mining announces new Payne's Find Lithium Project

PERTH, Australia, April 4, 2022 /PRNewswire/ -- Gold, lithium, and base metals exploration company Golden State Mining Limited (ASX code: "GSM") is substantially growing its' footprint acrossWestern Australia following the successful granting of two out of five tenement applications at GSM's new ...

2022-04-04 14:10 3194

Offering Investors a 16-hour Trading Window, Moomoo Achieves Record User Number

SINGAPORE, April 4, 2022 /PRNewswire/ -- Moomoo, the next-generation one-stop digital financial service platform, announced that it had accumulated over 18 million users from more than 200 countries and regions with its sister brand. Meanwhile, since its launch in 2018, moomoo has been supporting...

2022-04-04 09:30 5892

Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project

MELBOURNE, Australia, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been awarded$23 million in Federal Government grant funding under t...

2022-04-04 09:13 4470

LG RECEIVES AHRI PERFORMANCE AWARD FOR FIFTH CONSECUTIVE YEAR

Company Secures Sought-after Industry Recognition for Its Advanced HVAC Solutions in Six Different Product Categories SEOUL, South Korea, April 4, 2022 /PRNewswire/ -- LG Electronics (LG) has been honored by the Air-Conditioning, Heating & Refrigeration Institute (AHRI) with a Performance Award ...

2022-04-04 09:00 3138

EQTEC Announces Expansion Strategy Update in Asia

Developing technology and commercial partnerships to meet waste management targets, reduce emissions, and growing demand for energy, hydrogen and biofuels in the ASEAN region andSouth Korea HONG KONG, April 4, 2022 /PRNewswire/ -- EQTEC plc (AIM: EQT, "the Company"), a world-leading technology c...

2022-04-04 09:00 4132

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration ofChina ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine inChina. Pr...

2022-04-04 08:30 6023

Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022

SAN FRANCISCO and SUZHOU, China, April 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...

2022-04-04 08:00 4698

Commercial Launch: Illuccix® Now Available to Order in the United States

MELBOURNE, Australia and INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga 68 gozetotide), also known as68Ga-PSMA-11 injection, is now commercially...

2022-04-04 07:06 3271

Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong

HANGZHOU and SHAOXING, China, April 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the Hong Kong Special Administrative Region ofthe People's Republic of China ("H...

2022-04-03 18:20 4952

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China

SHANGHAI, April 3, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that the Center for Drug Evaluation (CDE) of the National Medical Products Admini...

2022-04-03 18:05 5272

Zoomlion Captures Broad Blue Ocean Market with Emerging Segments Account for over 20% of Total Revenue in 2021

CHANGSHA, China, April 2, 2022 /PRNewswire/ -- On March 30, Zoomlion released its 2021 annual report. The company secured operating revenue ofRMB 67.131 billion, up 3.11% year over year. Emerging segments such as aerial work machinery, earthmoving machinery, new building materials, agricultural ...

2022-04-02 12:24 10034

Peijia Medical Announces 2021 Annual Results

Dual Engines Promote Commercialization Total Revenue Increased by 253.2% HONG KONG, April 2,  2022 /PRNewswire/ -- Peijia Medical Limited ("Peijia Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 9996), a leading player in the high-growth transcatheter valve th...

2022-04-02 00:06 11252
1 ... 774775776777778779780 ... 901